chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tiredness; Muscle pain; sour; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731), via an unspecified route of administration on 17Apr2021 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient had a history of allergy to broad bean and bezoar. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Apr2021, the patient experienced tiredness, muscle pain and sour. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tiredness, muscle pain and sour was resolved on an unknown date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182), via an unspecified route of administration on 08May2021 (at the age of 27-year-old), as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Severe headache Stabbing, erratic pain on right scalp on top of head Extreme sensitivity/pain on top right scalp area Stabbing, erratic ear pain, right side Red, painful arm at injection site Lasted 7 days with pain Body aches
This spontaneous report as received from a medical assistant refers to an unknown number of patient of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (dose, route of administration, lot number and expiration date were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
On Dec 31, 2020 I began having pressure in chest, neck and headache and rapid heart rate. Normal B/P was now 150's/  diastolic 100's for 7 days. Saw PCP, referred to Cardiologist. Had Echo, EKG and stress test. EKG changes noted, "probably normal" stress test. B/P normalized by January 7 2021, tachycardia improved January 9.   Missed several days of work due to symptoms.
Generalized swelling to L thigh from injection site to knee. Skin warm; mottled ant. thigh, back of thigh nl.
Patient states that he began having a headache (frontal) that caused him to have some brain fog.  It lasted approximately four weeks.  It would wax and wane.  Then one morning he woke up without it. He was not seen for this.  Just happened to be seen today for his routine physical and mentioned it.
Patient received her first dose of the Covid-19 Moderna Vaccine. After about 5 minutes, she experienced a mild headache that then became sharp and severe. It quickly went away. She described no other symptoms. The pharmacist counseled the patient to watch and wait and that if her symptoms came back, did not improve, or worsen, that she should go to an urgent care. The patient left the pharmacy. A few hours later, the patient called the pharmacist and informed him that she went to the emergency room because she felt that her throat was closing. They administered a diphenhydramine drip and treated the patient's allergic reaction. The ER doctor stated to the patient that she had an allergy to come component of the Moderna and advised her not to receive the second dose. The patient was discharged.
This spontaneous report was received from a registered nurse referring to unspecified number of patients of unknown gender and age. The patients' pertinent medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX lot# M017294, expiration date 28-JUN-2017 (dose and route of administration were not reported) for prophylaxis. Administered doses of ZOSTAVAX were stored in -11.96 degrees Celsius for 15 hours, -11.5 degrees Celsius for 15 hours and in -14.61 degrees Celsius for 15 hours. There was no previous temperature excursion. No adverse event was reported. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1611USA011250.
Patient starting coughing up clear fluids around 9pm 8/13/20. Had diarrhea for the first 24 hours. Had nausea which lasted at least 4 days after vaccination. She also had fever and headache which was controlled with Tylenol.  Patient was in contact with PCP as well.
Shot given at 1045a at about 115am on 2/5/2021 chills, body aches, headache and nausea started. Chills wore off. Headache, aches and nausea remain at 530am
Fussy, alert, good color now, said to be irritable, staring, poor color in past 24 hrs. No seizure noted. P.E is essentially negative.
Injection in left arm at 4:15 pm.  on Friday 3/5/2021.  At 9pm, 3/5/2021 he complained of chest pain and was taken by ambulance to Medical Center Emergency Room.  He was diagnosed with gallstones and discharged at approx 4:00 am on 3/6/2021.  He found non responsive at home shortly thereafter.
Pain and inconsolable crying the day of. Continued inconsolable crying, abnormal behavior, emotional fits, inability to regulate emotions and reactions for 1 month. This was also a vaccine error. A human error was made on May 7, 2018, when the nurse assembled patient's vaccines. Instead of receiving DTP, MMR, and Polio vaccines, patient instead received PENTACEL (DTP + Hib + Polio), MMR, and Polio.  When asked how this occurred and why no one checked or double-checked the syringes, the doctor stated that the office usually has an oversight or check system, but it was not done for patient.  We were notified of the vaccine error on May 15, 2018.
immed p/vax devel red rash over inject site-lt arm; w/in 5 mins 3 small red areas were noted on chest; MD notified; no dyspnea noted; red aread noted on back; DPH;-ice pack
soreness in arm; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 86 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 11Feb2021 18:30 (Lot number: EN6201) at the age of 86 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Tetanus vaccine, for Immunization, reaction(s): "headache", "swollen arm", "rashness"; Flu vaccine, for Immunization; Pneumonia vaccine, for Immunization, reaction(s): "Headache", "Swollen arm", "Rash". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "soreness in arm".  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021501874 same patient/drug, different vaccine dose/AE
H1N1 intranasal administered without difficulty. Left vaccination area 15 min after adm. with no problems reported or observed. Went to class and returned complaining of headache and nausea - feeling tired. Vitals good, skin warm, dry no respiratory distress - walked in library with no assistance, gait good. Mom picked child up from school 1-1 1/2 hrs past adm.
On 09/24/2005 Patient began experiencing migratory urticaria approximately started mid day. Since 09/24/2005 has experienced migratory urticaria. Seen by above provider 09/27/2005 exam negative script from Zyrtec 10 mg daily x 10 days given.
Urticaria within seconds of receiving Varivax and MMR. Twin same vaccine, same reaction.
Pt received MENACTRA vaccine in Lt deltoid at 1030-at 1035 pt became unresponsive with involuntary movements of her ext-lasted < 20 sec.
Apparent breakthrough varicella lesions approximately 3 years after vaccination. 8 to 10 varicelliform lesions and fever.
headache, body ache, chills, fatigue, sore arm, Nausea
Vomiting x 2, pale, limp, HR+RR normal (per mom), MD on call told to watch, next am T 101.2 and back to normal self.
April 15th started getting weak and off balance. April 25th developed tinnitus. 2021
Pt turned blue, CPR ADMINISTERED, transported by ambulance. DIAGNOSED AS FEBRILE SEIZURE
Started out as regular period but continued to bleed well after normal cycle end.  Got the first COVID shot in the middle of normal period cycle. April 12, 2021; Before seeking medical treatment/ advice, took a pregency test, it was positive. Went to ER, as IUD was still in place. Blood tests were done as well as ultrasounds. Eptopic pregnency, failure of IUD. Removal of IUD, 3 Methotrexate shots later. HAd to take 3 weeks off of work.
The patient began experiencing a loss of taste approximately 1 week after receiving the vaccine. The loss of taste increased over time and currently has no sense of taste. Patient has received no treatment at this time and reported this adverse effect at office visit with PCP.
pt started having symptoms 2 days after getting the vaccine.  It started with vomiting, body aches and fever and he continued to decline.   He went to ER with worsening abdominal pain.  He was given a CT.  He was treated for diverticulitis.  He was sent home with antibiotics.  He did not improve and went back to same ER. He was transferred an unspecified hospital. He has septic thrombose inferior mesenteric vein which is protruding into the junction of the portal vein and SNV.  He in currently in ICU on heparin and watching him for any acute mesenteric ischemia.  Blood Culture is positive for E.coli.
Red,raised, 2 inch bump at injection site, itchy, very warm to touch.  Just noticed it today.
This spontaneous report was received from a medical assistant referring to an 18 months old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medication included sterile diluent (manufacturer unknown). On 15-MAR-2018, the patient was administered an improperly stored (Oka/Merck) VARIVAX (lot reported as: N022978; Expiry date: 23-AUG-2019) (product storage error) reconstituted with a properly stored sterile diluent (lot and expiry date not reported) for prophylaxis. The vaccine was exposed to 15 °F to 46°F (32.2°F) for 9 hours and 27 minutes. There was no previous temperature excursion. There was no involvement of digital data logger. This is one of the several cases received from the same reporter.
DAY 1 - 8/23 - Left arm hurts, very nauseated with chills and very weak all day.  DAY 2 - 8/24 - Arm is very painful & very fatigued. DAY 3 - 8/25 - Arm still sore, red & swollen at injection sight DAY 4 - 8/26 - Arm still sore, red & swollen DAY 5 - 8/27 Arm not quite as sore, turning pink but itchy. DAY 6 - 8/28 Same as above DAY 7 - 8/29 Finally felt better.
pt recvd vax;on 7dec94 PC from mom reporting pt had inc fever of 105,on apap;pt was very irritable since 2dec in pm; leg was swollen, warm  & firm to touch surrounding inject site;on 6dec t 99; reported better on 7dec94;
Lt upper arm swollen & red rxn w/in 30minutes; Cold compress applied 2 tsp DPH;
Patient received the new Spikevax and a couple of days later stated that she feels like she has fluid in her lungs.  She said it hurts when she breaths and coughs.  It has been 6 days since the vaccine and she said she feels a little bit better, but she knows she has fluid in the lungs.
March 15th COVID shot.  March 16th started to get severe dizziness and fatigue. Went to bed early.  March 17th speech was impaired and difficulty with gait and balance. Admitted to MAMC ER, which confirmed a stroke and released.  March 18th early AM admitted again to ER due to unable to move/walk. Due to lacking proper equipment and space was transferred via ambulance to hospital in March 18th until March 24 Obeservations Inpatient at Hospital. March 24 to April 16th Inpatient rehab.
Developed a fever of 104F at 14 hours after injection.  After taking acetaminophen, the fever dropped to around 101 and stayed there for 12 hours before subsiding.  Body aches and extreme fatigue were also present.  48 hours after injection (03/08/2021) I woke up with major skin irritation.  There were no visible signs like a rash or any redness, but my skin felt sunburned and wearing clothes was extremely uncomfortable.  This lasted until 03/10/2021.  I used lotions and took cool showers to help with the symptoms.
Healthy individual with no underline conditions and on 10/31/2021 I had two minor strokes with no route cause determined after multiple tests
Left arm  swollen from injection to below elbow...itching - red ...having difficulty using my  fingers
After sitting down in the 15 minute waiting area, patient fainted. She was immediately given medical attention by the pharmacist. EMT's were called and pt was given additional EMT medical attention.
Large swollen area and "knot" on leg. Saw a second Dr Sat 5/12/12 who gave oral abx, oral liquid (antihistamine?) and cream;  Pt refused oral meds but was much better by Monday 5/14/12 with cream only.
april 29 started complaining  about stomach pain, may 10 got hospitalized because still had not been able to poop since vaccine. they gave her a whole bottle of meds to help her go. xray showed the left side was completely blocked. may 18th got 2nd vaccine and still hadn't been able to really use bathroom just a little bit. may 20 was finally able to go to bathroom after Dr prescribed her a different medication but now she is having to remain on that medication.  she had covid back in Jan
she got this transplant, she, she caught the, the virus/liver transplant; She caught the, the virus.; She had got the shot three months prior.She caught the, the virus.; This is a spontaneous report   from a non-contactable Other HCP. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient had a liver transplant, she caught the virus/liver transplant. She had got the shot three months prior. She got this transplant, she, she caught the, the virus. The patient underwent lab tests and procedures which included sars-cov-2 test: positive.  Outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on plausible temporal relationship, a possible causal association between the events "Liver disorder, COVID-19 " and the suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in re-sponse, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Fever  Chills Rigors Nausea  Sweats  Diarrhea  Headache Hypotension
fever and decreased appetite. Exclusively formula fed infant who is mildly dehydrated, mom reports only 1oz formula taken this morning no wet diapers.
Two blood clots in the posterior lobes of her lung; heart rate was really fast; A spontaneous report was received from a 69 year-old female consumer who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced two blood clots in the posterior lobes of her lung and heart rate was really fast.   The patient's medical history included diverticulitis. Consumer mentioned that she was recovering from diverticulitis when she received the first Moderna vaccine.  Products known to have been used by the patient, within two weeks prior to the event, included flagyl, bactrim, clindamycin (for a dental procedure one day after her vaccine), famotidine, lorazepam and elavil.  On 09 Feb 2021, four days prior to the onset of the events, the consumer received their first of two planned doses of mRNA-1273 (lot/batch: 030M20A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 12 Feb 2021, the consumer experienced really fast heart rate and went to urgent care.  The patient was referred to the hospital where it was found that the patient had two blood clots in the posterior lobes of her lung and she was hospitalized. Treatment for the event included heparin bolus (dose and duration) not specified. The patient was discharged on 13 Feb 2021 and started on Eliquis 5 mg twice a day.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events was resolved.  The assessment for the events was not provided.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Approximately 15 minutes after vaccination, child presented with welps and red splotches on face and trunk with lips and nose swelling. No wheezing noted. MD treated immediately with Celestone and Depo-Medrol IM. Symptoms resolved within 15 minutes of med administration.
Vaccine recipient complained of lightheadedness. States feels "relaxed" "lazy" at approximately 10 minutes after receiving vaccine.  Initial VS at 1050, BP 154/101, HR 81. Vaccine recipient reports erythema to chest that he states "was not there before." No shortness of breath reported.  Continued vital signs as follows: 1055 BP 162/97, HR 75; 1100, BP 152/101, HR 75; 1105, BP 177/100, HR 80; 1111, BP 37/108, HR 74; 1115, 142/98, HR 72; 1115, BP 142/98, HR72; 1120, BP 149/98, HR71. Benadryl 25mg given via IV at approximately 1115 by EMS. Decision to take vaccine recipient to Hospital. To hospital via ambulance at 1136.
Hives on his wrist, feet, torso, and arms.  Everywhere but his face.  Complained of severe leg pains.
Ran a temp, very sore arm. Left arm has remained sore for months now. It seems to be from the area the shot was in.
Fever of 101 degrees Achy muscles Large red hot area of 3inch diameter around the injection site
Patient did not have any adverse events following the covid vaccine. The patient was instructed to wait the minimum of 15 minutes to ensure he did not have any symptoms. A follow up call was placed to the patient to see how he was doing, patient stated that he was ok.
The pt was vaccination in 8/00. The pt experienced redness and mild swelling at the injection site on the left arm and fever of 102. Additional information has been requested.
Extreme Pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administration date 19Feb2021 (Batch/Lot number: unknown) at the age of 66 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN), for covid-19 immunisation. The following information was reported: PAIN (non-serious) with onset 20Feb2021, outcome "recovered" (21Feb2021), described as "Extreme Pain".  Additional information: Extreme pain lasted about 24hrs had second shot on Feb 19th and was the next day when all this occurred.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Day after vaccine -headache, fever, fatigue, body aches       Two weeks after vaccine-fever, rash on arms and legs, headache, dizziness, fatigue, intermittent nausea
3-1-21 swollen lymph node in groin area. Shingles on 4-9-21, is getting treated with antiviral and gabapentin
Blood pressure at 4 pm on 3 March was 150. By 8 pm that evening it was 197. Had slight head ache and face was red. Went to the ER. That night I experienced moderate chills.
fever of over 100; Aches; Nausea; This case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced fever, pain and nausea. On an unknown date, the outcome of the fever, pain and nausea were recovered/resolved.   It was unknown if the reporter considered the fever, pain and nausea to be related to Shingrix.     Additional Information: GSK Receipt Date: 20-MAY-2022 Reporter's Comment: The patient self-reported this case. The patient received dose of Shingrix vaccine approximately 3 months ago and experienced fever of over 100, aches and nausea. The patient stated that all symptoms had resolved.  The patient did not consent to follow-up.
Complaining of under arm pain/unable to lift arm without pain; golf ball size swelling of lymph node; Also complained of headache; bellyache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 10 year-old male patient received bnt162b2 (BNT162B2), (tirs),  intramuscular, administered in arm, administration date 30Nov2021 16:30 (Lot number: FK5127) at the age of 10 years as dose 2 , single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MULTIVITAMIN [VITAMINS NOS]. Vaccination history included: Bnt162b2 (1st dose of covid vaccine, lot No.- FK5127, Time: 16:30, Anatomical location: Arm, Route of administration: Intramuscular), administration date: 09Nov2021, when the patient was 10 years old, for COVID-19 immunization. The following information was reported: AXILLARY PAIN (non-serious) with onset 01Dec2021, outcome "recovered" (Dec2021), described as "Complaining of under arm pain/unable to lift arm without pain"; LYMPHADENOPATHY (non-serious) with onset 01Dec2021, outcome "recovered" (Dec2021), described as "golf ball size swelling of lymph node"; HEADACHE (non-serious) with onset 01Dec2021, outcome "recovered" (Dec2021), described as "Also complained of headache"; ABDOMINAL PAIN (non-serious) with onset 01Dec2021, outcome "recovered" (02Dec2021), described as "bellyache". Therapeutic measures were taken as a result of axillary pain, lymphadenopathy, headache. Therapeutic measures were not taken as a result of abdominal pain.  Additional Information: Twin sister received the same dose at same time and is also experiencing under arm pain but very little swelling, no headache, and no bellyache. No information reported on Specific relevant test for thromboembolic events with thrombocytopenia. No further details on patient was reported.   No follow-up attempts are possible. No further information is expected.
My 7y/o son had a hard large moveable lump alongside his jawline. It was 1cm x .5 cm. I took him to the pediatricians office the day after we noticed it. The doctor said it felt like a large lymph node, which was a reaction to the COVID-19 vaccine and it should go down with time. I had never felt a lymph node like that - that size and firmness.
1st dose;  Nausea, vomiting, 101 fever, chills, weakness
Left arm soreness at the injection site on 12/23 at 7:45 am
Fever - 102, chills for 12 hours, followed by 101 fever for 12 more hours
Cellulitis; Fatigue Information has been received from a physician concerning a 37 year old female with sulfa allergy and a history of migraine who on 24-OCT-2005 at 5:00 PM was vaccinated with pneumococcal 23v polysaccharide vaccine (lot #651318/1006P), in the left arm upper arm. On 24-OCT-2005 the patient's left arm became swollen with pain, heat and fever (40 C). The patient took diphenhydramine HCL (Benadryl), "which helped a little." On 27-OCT-2005 she was seen by the doctor and she was given an antibiotic. Subsequently it was reported that the patient developed cellulitis of the left side arm 30x30cm red, hot, temperature 101.4, very tired. The patient was treated with cephalexin (Keflex) and antihistamine. The patient had "not yet" recovered. Additional information has been requested.